Upcoming Webinar
The JPM “Post-Conference”: Medtech Insights and 2023 Expectations
Date: Tuesday, February 7, 2023
Time: 2:00PM ET / 11:00AM PT
Moderator:
Lynn Pieper Lewis
Founder & CEO, Gilmartin Group
Speakers:
Annie Wernig,
Managing Director,
Healthcare Investment Banking,
J.P. Morgan
Benjamin Burdett,
Managing Director,
Healthcare Equity Capital Markets,
J.P. Morgan
The JPM “Post-Conference”: Medtech Insights and 2023 Expectations
2023 was the first in-person J.P. Morgan Conference in recent years and San Francisco welcomed the healthcare community back with open arms. In this webinar, we’ll be taking a deeper dive into the trends and insights that emerged from the conference with the hosts of the main event, J.P. Morgan.
Featured Speakers
Annie Wernig
Managing Director, Healthcare Investment Banking, J.P, Morgan
Read Biography
Annie Wernig is a Managing Director in J.P. Morgan’s Healthcare Investment Banking Group, focused on the Medical Device sector. Annie joined J.P. Morgan in 2013 and has primarily covered the medtech landscape since then. She advises clients across M&A and capital raising transactions, including private placements, IPOs and follow-on offerings as well as debt offerings. She holds a B.A. in Economics from Princeton University and an MBA from the University of Virginia’s Darden School of Business.
Benjamin Burdett
Managing Director, Healthcare Equity Capital Markets, J.P, Morgan
Read Biography
Annie Wernig is a Managing Director in J.P. Morgan’s Healthcare Investment Banking Group, focused on the Medical Device sector. Annie joined J.P. Morgan in 2013 and has primarily covered the medtech landscape since then. She advises clients across M&A and capital raising transactions, including private placements, IPOs and follow-on offerings as well as debt offerings. She holds a B.A. in Economics from Princeton University and an MBA from the University of Virginia’s Darden School of Business.
Moderator
Lynn Pieper Lewis
Founder & CEO, Gilmartin Group
Read Biography
Lynn founded Gilmartin Group with the belief that companies deserve better advice. She has spent the bulk of her career on Wall Street, accumulating 20 years of experience writing research, analyzing and advising entities in the healthcare industry. Having created and executed investor relations programs and strategies for over 50 companies at various stages of development, Lynn has a proven track record of success.
Our Clients
Our clients are leaders and innovators across the MedTech, Biotechnology, Digital Health, Life Science Tools & Diagnostic sectors
Resources
Gilmartin has a number of resources, from blog posts to webinars designed to educate and help your company achieve success.